UNIGE document Scientific Article
previous document  unige:46329  next document
add to browser collection
Title

Recombinant tissue plasminogen activator induces blood-brain barrier breakdown by a matrix metalloproteinase-9-independent pathway after transient focal cerebral ischemia in mouse

Authors
Bengualid, Daniel Jiménez
Da Silva, Rafaela F
Kargiotis, Odysseas
Published in European Journal of Neuroscience. 2011, vol. 34, no. 7, p. 1085-92
Abstract The role of the inducible matrix metalloproteinase (MMP)-9 in blood-brain barrier (BBB) disruption after ischemic stroke is well accepted. Recombinant tissue plasminogen activator (r-tPA) is the only approved thrombolytic treatment of ischemic stroke but r-tPA is potentially neurotoxic. Vasogenic edema after r-tPA treatment has been linked with an increase in cerebral MMP-9. However, because cerebral ischemia clearly increases the levels of endogenous tPA, the consequence of additional r-tPA may be questionable. In this study, wild type and MMP-9 knockout mice were subjected to 90 min transient middle cerebral artery occlusion and treated with 10 mg/kg r-tPA. At 24 h after occlusion, BBB permeability, hemispheric enlargement, collagen and laminin degradation as well as cerebral infarction were increased in both wild type and MMP-9 knockout treated animals as compared with non-treated animals. Mortality was increased in wild type but reduced in knockout treated mice. Cerebral MMP-9 concentration was not modified by r-tPA. However, pre-treatment with p-aminobenzoyl-gly-pro-D-leu-D-ala-hydroxamate, a broad-spectrum MMP inhibitor, counteracted the effects of r-tPA on the neurovascular unit and decreased mortality in both wild type and knockout mice. MMP inhibition did not modify cerebral infarction in r-tPA-treated animals. Our results suggest that r-tPA toxicity is mainly independent of MMP-9 after transient middle cerebral artery occlusion but could involve some other MMPs. Additionally, our results support the hypothesis of a dissociation between r-tPA-dependent mechanisms of BBB breakdown and cerebral infarction. Due to the importance of r-tPA in thrombolytic treatment of ischemic stroke patients, the MMPs that could participate in r-tPA-induced BBB disruption should be further characterized.
Keywords AnimalsBlood-Brain Barrier/drug effects/metabolism/pathologyBrain Ischemia/metabolism/pathologyCollagen Type IV/metabolismFibrinolytic Agents/pharmacologyLaminin/metabolismMaleMatrix Metalloproteinase 9/genetics/metabolismMiceMice, KnockoutStroke/metabolism/pathologyTissue Plasminogen Activator/pharmacology
Identifiers
PMID: 21895804
Full text
Article (Published version) (515 Kb) - document accessible for UNIGE members only Limited access to UNIGE
Structures
Research group Groupe Gasche Yvan (Soins intensifs) (501)
Citation
(ISO format)
COPIN, Jean-Christophe et al. Recombinant tissue plasminogen activator induces blood-brain barrier breakdown by a matrix metalloproteinase-9-independent pathway after transient focal cerebral ischemia in mouse. In: European Journal of Neuroscience, 2011, vol. 34, n° 7, p. 1085-92. https://archive-ouverte.unige.ch/unige:46329

157 hits

0 download

Update

Deposited on : 2015-02-04

Export document
Format :
Citation style :